Login / Signup

VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy.

Marion MagnolLoukianos CouvarasYannick DegboéEric DelabesseCristina Bulai-LivideanuAdeline Ruyssen-WitrandArnaud Constantin
Published in: Rheumatology (Oxford, England) (2021)
Keyphrases
  • case report
  • ankylosing spondylitis
  • high dose
  • disease activity
  • stem cells
  • rheumatoid arthritis
  • low dose
  • mesenchymal stem cells
  • smoking cessation